key: cord-0966204-4j9gigdp
authors: Sperandeo, Marco; Trovato, Guglielmo M
title: Lung Ultrasound early detection and monitoring in Covid-19 Pneumonia: fact and fiction
date: 2020-05-14
journal: QJM
DOI: 10.1093/qjmed/hcaa165
sha: 8207a8460e553fa008b4a19c0a34fa3ffe9b709e
doc_id: 966204
cord_uid: 4j9gigdp

nan

Dear Editor.

The case report of "serial bedside lung ultrasonography in a critically ill COVID-19 patient" 1 observed in an Hospital, in China deserves few comments, according to serial lung ultrasound (US) routinely performed in our Institution (CSS-Hospital, February-April 2020). We searched in COVID-19 patients lung consolidation early and concurrently with CT. CT scan detection was actually confirmed by Lung US later in fewer patients. L Ji et al. state that their patient had two ground-glass opacity, one at the posterior-right site, and one, quite tiny, lateral 1 .

With such CT abnormalities, according to our experience, a COVID-19 patient should be asymptomatic, unless there where present co-morbities. 2 In their single case, actually, there was a previous diagnosis of systemic lupus erythematosus: nevertheless, surprisingly, no other lesion was detected by CT, as it is usual in Lupus patients. 3 Despite the claim of referring to imaging, assessment of severity and monitoring of improvement of this patient relies purely on the B-lines count 1 . This approach is not reliable. B-lines are ultrasound imaging errors, namely "artifacts", depending on the great difference in acoustic impedance encountered by the ultrasound beam crossing surfaces with a different density (i.e. chest wall/aerated lung or gas/fluid-film). pneumonia therapy, which is consistent with chest CT features. Bedside LUS may present a useful and non-invasive method to monitor serial changes in COVID-19 pneumonia." 1 It is not clear what does exactly mean "Serial bedside lung ultrasonography" monitoring, because, seemingly, this patient was assessed, appropriately by a CT scan at the onset and when improves. When present, a diffuse lung involvement in COVID-19 disease has more complex and relentless development, which the claimed "response to COVID-19 pneumonia therapy" 1 would not modify so quickly.

Usefulness and features of the performed US monitoring lack in this report. 1 Caution reporting and disseminating information on Lung US use in COVID-19 patients is mandatory. Lung US early detection and monitoring, better fitting than CT scan, is an impracticable and naïve assertion 1 , suggesting an approach unacceptable when facing with the overwhelming surge of patients calling for optimizing workflows for rapid diagnosis and care.

Serial bedside lung ultrasonography in a critically ill COVID-19 patient

The lung in systemic vasculitis: radiological patterns and differential diagnosis

Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions?

Interstitial Lung Disease

The artificial count of artifacts for thoracic ultrasound: what is the clinical usefulness?

Sounds, ultrasounds, and artifacts: which clinical role for lung imaging?